Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
Vittorio Pavoni, Lara Gianesello, Andrew P. Horton
Topics & Concepts
MedicineEpiphenomenonDiseaseThrombosisCoronavirus disease 2019 (COVID-19)PathogenesisIncidence (geometry)HematologyVenous thrombosisVenous thromboembolismAntiphospholipid syndromeIntensive care medicineInternal medicineImmunologyInfectious disease (medical specialty)PhilosophyOpticsPhysicsEpistemologyCOVID-19 Clinical Research StudiesSystemic Lupus Erythematosus ResearchDermatological and COVID-19 studies